India diclofenac sodium market is expected to grow at a steady rate during the forecast period. Increasing aging population in the country is the key factor which is estimated to drive the India Diclofenac Sodium market over the forecasted years. In addition to this, high growth in the number of surgeries taking place is further expected to rev up the market growth through FY2026. Additionally, supportive government policies and improving healthcare infrastructure are some other reasons that are expected to create lucrative opportunities for the market growth over the next few years.
The India diclofenac sodium market is segmented based on product type, form, application, route of administration, source, distribution channel, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. Out of which, the in-house segment dominated the market until FY2020 owing to in house production preference by the major market players. The contract manufacturing organizations segment is expected to witness significant growth during the forecast period on account of upsurge in the number of contract manufacturers in the country and increased outsourcing activities by the major companies in order to focus on their R&D activity and expansion plans. Additionally, contract manufacturing organizations offer competitive pricing and can provide bulk orders in lesser duration. This is further projected to contribute to the segmental growth in the coming years.
The major players operating in the India diclofenac sodium market are Novartis India Ltd, Hetero Drugs Ltd., Auro Laboratories Ltd., Aarti Drugs Ltd., J B Chemicals and Pharmaceuticals Ltd., Novartis India Ltd., Emkay Pharma Pvt. Ltd., Bestochem Formulations (India) Limited, Salvavidas Pharmaceutical Pvt. Ltd., Wellona Pharma Pvt. Ltd and others. Major companies
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India diclofenac sodium market from FY2016 to FY2019.
- To estimate and forecast the market size of India diclofenac sodium market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India diclofenac sodium market based on product type, form, application, route of administration, source, distribution channel, end user, company and regional distribution.
- To identify dominant region or segment in the India diclofenac sodium market.
- To identify drivers and challenges for India diclofenac sodium market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India diclofenac sodium market.
- To identify and analyze the profile of leading players operating in India diclofenac sodium market.
- To identify key sustainable strategies adopted by market players in India diclofenac sodium market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Diclofenac sodium manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to diclofenac sodium
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
